Maypharm Co., Ltd.
Hyalmass 60cc
Brand
Maypharm Co., Ltd.
Category
Body Filler
Origin
Korea
Interested in ordering Hyalmass 60cc? Send an enquiry and our team will follow up with availability and pricing.
Overview
Hyalmass 60cc is a Korean hyper-cross-linked hyaluronic acid filler from Maypharm, supplied as a large 60cc vial for body augmentation. It is formulated with Maypharm's Hybrid (Hy-BRID) cross-linking technology to produce a dense, high-lift HA gel for large-volume contouring. The vial format is intended for convenience and efficiency in extensive body procedures.
How it works
The hyper-cross-linked HA gel is placed in deep tissue planes where its high density and viscoelasticity provide strong lift and durable volume across large areas. The dense cross-linked matrix is designed for high lifting capacity and resistance to breakdown, maintaining contour until gradual resorption. It is dissolvable with hyaluronidase for correction.
Indications
- Buttock (gluteal) augmentation
- Hip contouring and hip dip correction
- Calf / leg contouring
- Large-area body contour correction
- Deep volume restoration
Key features
- Hyper cross-linked, high-density HA (Hybrid technology)
- High lifting capacity and viscoelasticity
- Large 60cc vial for body augmentation
- Non-animal hyaluronic acid
- Hyaluronidase-reversible
Benefits
- High-density gel suited to strong, durable lift in large areas
- Vial format efficient for extensive body volumizing
- Non-surgical alternative to implants or fat transfer
- Reversibility supports clinical risk management
- Established Korean manufacturer suits verified B2B sourcing
Composition
Hyper cross-linked, high-density hyaluronic acid (Hybrid/Hy-BRID cross-linking technology), non-animal origin; 60cc vial. Exact HA mg/mL is not consistently published across sources.
Usage & handling
For deep-plane placement by a trained injector via blunt cannula from the vial under strict asepsis. Dense high-lift gel suits structural volumizing; use staged sessions, aspiration and retrograde technique for large-volume safety. HA-based and reversible with hyaluronidase. The line is reported by the manufacturer to have obtained CE marking (2023).
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.